1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...

The White House recently announced that it is raising the fee on H-1B visas to $100,000, which have typically cost between $5,000 to $10,000, for individuals who applied after September 21, 2025. Some ...

Background: Rucaparib (CO-338) is an oral small molecule inhibitor of poly (ADP-ribose) polymerase (PARP) that is being developed for patients with BRCA1 and BRCA2 mutated and homologous recombination ...

1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.

1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...

Background:. A critical component of oncogenesis and cancer progression is metabolic re-programming of cells to enable continuous growth. Oncogenic activated signaling pathways can drive de novo ...

1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...

STAT3 palmitoylation increases dimerization, nuclear localization, and activation of target genes. Major Finding: STAT3 palmitoylation increases dimerization, nuclear localization, and activation of ...

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...

1Abramson Cancer Center and Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Cancer Res (2024) 84 (7_Supplement): LB055.